Related Experiment Video
Updated: Jan 6, 2026
05:39
Spontaneous Murine Model of Anaplastic Thyroid Cancer
Published on: February 3, 2023
2.1K
Progress in Drug-targeted Therapy for Papillary Thyroid Carcinoma
Bin Wang1, Limin Xu2, Menglong Rui3
1Thyroid and Breast Surgery Department, Gaochun People's Hospital of Nanjing, Nanjing, China.
Current Oncology Reports
|October 22, 2025
Summary
Advanced papillary thyroid carcinoma (PTC) presents treatment challenges. Targeted therapies offer innovative pharmacological options for managing advanced or resistant PTC, improving patient outcomes.
Area of Science:
- Oncology
- Pharmacology
- Endocrinology
Background:
- Papillary thyroid carcinoma (PTC) is the most common thyroid cancer.
- Early-stage PTC generally has a good prognosis.
- Advanced or metastatic PTC poses significant therapeutic challenges.
Purpose of the Study:
- To review current pharmacological interventions for PTC.
- To emphasize targeted therapies in advanced PTC.
- To summarize progress, challenges, and future directions of targeted drug therapy for PTC.
Main Methods:
- Review of contemporary pharmacological interventions for PTC.
- Focus on targeted therapies and their molecular pathways.
- Analysis of clinical efficacy, resistance mechanisms, and response strategies.
Main Results:
- Conventional therapies are effective for early-stage PTC.
- Advanced PTC, especially resistant forms, requires innovative treatments.
- Targeted therapies are a key focus for advanced PTC management.
Conclusions:
- Targeted therapies represent a significant advancement in managing advanced PTC.
- Understanding molecular pathways and resistance is crucial for optimizing treatment.
- Drug-targeted therapy is integral to the comprehensive treatment of PTC.
Related Concept Videos
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
01:26Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
411
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
411
01:26Targets for Drug Action: Overview
9.9K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
9.9K
02:50Combination Therapies and Personalized Medicine
5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K